AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glycichek MV 1mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Astorion Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Glycichek MV 1mg/500mg/0.2mg Tablet

DiaBeta-Combo (1mg/500mg/0.2mg) tablets are classified as antidiabetic agents, a combination medication for adult type 2 diabetes management. This treatment helps regulate blood glucose levels. DiaBeta-Combo should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, risking kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is part of a comprehensive diabetes management plan that incorporates a balanced diet, exercise, and weight management, as directed by your doctor. Lifestyle choices significantly impact diabetes control. The most prevalent adverse effect is hypoglycemia (low blood sugar), characterized by symptoms like sweating, dizziness, headache, and tremors. Carry a fast-acting glucose source, such as sugary snacks or juice, to counter this. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain is also a possibility. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their doctor before commencing treatment. Pregnant or lactating women should consult their physician before use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.

Uses of Glycichek MV 1mg/500mg/0.2mg Tablet

Managing type 2 diabetes

Major Benefits of Glycichek MV 1mg/500mg/0.2mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glycichek MV 1mg/500mg/0.2mg Tablet whole; do not chew, crush, or divide it. Administer on an empty stomach.

Common Side effects of Glycichek MV 1mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glycichek MV 1mg/500mg/0.2mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glycichek MV 1mg/500mg/0.2mg Tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.

How Glycichek MV 1mg/500mg/0.2mg Tablet works:

One tablet of Glycichek MV contains 1mg, 500mg, and 0.2mg of three distinct antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glycichek MV 1mg/500mg/0.2mg tablets with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glycichek MV 1mg/500mg/0.2mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Breastfeeding while taking Glycichek MV 1mg/500mg/0.2mg tablets is likely inadvisable. Available evidence in humans indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyUNSAFE

Glycichek MV 1mg/500mg/0.2mg Tablets pose a likely risk for individuals with kidney impairment and should be omitted. Medical advice is recommended. Furthermore, this medication is unsuitable for patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Patients with liver impairment should use Glycichek MV 1mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Glycichek MV 1mg/500mg/0.2mg Tablet :

Should you forget to take a Glycichek MV 1mg/500mg/0.2mg Tablet, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glycichek MV 1mg/500mg/0.2mg Tablet

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Glycichek MV 1mg/500mg/0.2mg Tablet

Glycichek MV 1mg/500mg/0.2mg tablets contain glimepiride, metformin, and voglibose. This triple-drug formulation manages type 2 diabetes mellitus in adults. Effective blood sugar control requires its use alongside a balanced diet and regular physical activity. Glimepiride stimulates pancreatic insulin secretion, reducing blood glucose. Metformin decreases hepatic glucose production and enhances insulin responsiveness. Voglibose, an alpha-glucosidase inhibitor, reduces post-meal blood sugar elevation. This medication is unsuitable for type 1 diabetes.
Taking Glycichek MV 1mg/500mg/0.2mg Tablets may result in common adverse reactions including low blood glucose, queasiness, loose stools, taste disturbances, gas, abdominal discomfort, cephalalgia, dermatitis, and upper respiratory infections.
Patients with hypersensitivity to Glycichek MV 1mg/500mg/0.2mg Tablet constituents or inactive ingredients should not take this medication. Its use is contraindicated in individuals with moderate to severe renal impairment, inflammatory bowel disorders, colonic ulcers, and underlying metabolic acidosis, such as diabetic ketoacidosis.
Consuming alcohol concurrently with Glycichek MV 1mg/500mg/0.2mg Tablet is inadvisable. This combination risks dangerously low blood glucose (hypoglycemia) and elevates the likelihood of lactic acidosis.
Indeed, Glycichek MV 1mg/500mg/0.2mg Tablets may induce hypoglycemia. Low blood sugar symptoms encompass nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. These effects are amplified by skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying readily available glucose sources, such as glucose tablets, honey, or fruit juice, is advisable.
Retain this medication within its original, sealed packaging. Follow the storage guidelines provided on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and others.
Glycichek MV 1mg/500mg/0....
74
MRP 90
17% off